DJIA 16,461.32 0.00 0.00%
NASDAQ 4,382.85 0.00 0.00%
S&P 500 1,945.30 18.19 0.94%
market minute promo

Dendreon Corp (NASDAQ: DNDN)

1.04 0.01 (0.97%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

DNDN $1.04 0.97%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.09
Previous Close $1.03
Daily Range $1.01 - $1.09
52-Week Range $0.89 - $3.52
Market Cap $166.7M
P/E Ratio -0.81
Dividend (Yield) $0.00 (0.0%)
Volume 1,653,034
Average Daily Volume 2,241,262
Current FY EPS -$0.74

Sector

Healthcare

Industry

Drugs

Dendreon Corp (DNDN) Description

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. Website: http://www.dendreon.com/

News & Commentary

The 1 Biotech Stock I'm Definitely Not Buying

Three of our analysts chime in on which biotech stocks they think are the most risky.

Dendreon: Time To Answer Questions

Griffin Securities' Keith Markey On The Promise Of RNAi And Synthetic Biologics

A Lesson Learned: The Unfortunate Case Of GT Advanced Technologies

Cheap Stocks Wall Street Loves: Medivation

Medivation stock is up more than 1,000% over the past three years and yet is still considered a cheap stock when using this Wall Street metric. Find out why Wall Street has fallen in love with Medivation, and whether or not the stock can head higher.

Why Northwest Biotherapeutics Inc. Stock Skyrocketed 36% in 2014

Northwest Biotherapeutics stock has soared this year on the heels of three catalysts. Find out what those catalysts are and whether or not NW Bio still has legs.

Dendreon Short Interest Hits Critical Point

Dendreon (DNDN) in Focus: Stock Up 9.4% - Tale of the Tape

Dendreon (DNDN) in Focus: Stock Up 9.4% - Tale of the Tape

Tokai Pharmaceuticals IPO: Lack Of Product Diversity Should Leave Investors Cautious

Why Inovio Pharmaceuticals Inc. Plunged By 10% in 2014

Cancer immunotherapy vaccine developer Inovio Pharmaceuticals has largely underperformed the market in 2014. Find out what's keeping the stock down and whether or not Inovio shares are poised for a rebound.

See More DNDN News...

DNDN's Top Competitors

DNDN $1.04 (0.97%)
Current stock: DNDN
AMGN $146.90 (2.27%)
Current stock: AMGN
GILD $106.19 (0.09%)
Current stock: GILD
BIIB $313.76 (1.52%)
Current stock: BIIB